BSEResult4d ago · 31 Jul 2026, 03:24 pm
Please find attached the financial results for the Quarter ended June 30, 2026
Astec Lifesciences Ltd · 533138
✦ AI SummaryResults
Astec Lifesciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a loss of Rs. 1,873.82 lakhs before tax and Rs. 1,870.73 lakhs after tax.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment3/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Astec Lifesciences Ltd - 533138 - Financial Result For The Quarter Ended June 30, 2026
Attachments (1)
📄pdf
Download →
606f2dce-0e7b-491c-acc7-aae65dd2767a.pdf
View document text
Date: 31st July, 2026
To, To,
BSE Limited National Stock Exchange of India Limited
P. J. Towers, Dalal Street, Fort Exchange Plaza, Bandra - Kurla Complex,
Mumbai – 400 001 Bandra (East), Mumbai-400 051
Ref.: BSE Scrip Code No. “533138” Ref.: “ASTEC”
Debt Segment NSE:
NCD-ASTEC-ISIN: INE563J08023
Sub.: Outcome of the Board Meeting
Pursuant to Regulations 30, 33 and 52(4) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) read with
Schedule III to the said Regulations, this is to inform you that the Board of Directors of the
Company, at its Meeting held today, i.e., on Friday, 31st July, 2026 (which commenced at 2.00
p.m. and concluded at 3. p.m.), inter alia, has approved / noted the following:
(a) Approval of the Unaudited Financial Results (Standalone & Consolidated) for the
Quarter ended 30th June, 2026:
Upon recommendation of the Audit Committee, the Board of Directors has approved the
Unaudited Financial Results (Standalone & Consolidated) as per Indian Accounting
Standards (IND AS) for the Quarter ended 30th June, 2026 (enclosed herewith).
(b) Noting of the Limited Review Reports of the Statutory Auditors for the Quarter ended
30th June, 2026:
The Board of Directors took note of the Limited Review Reports of the Statutory Auditors on
the Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended 30th
June, 2026 (enclosed herewith).
The Limited Review Reports of the Statutory Auditors are with unmodified opinion with
respect to the Unaudited Financial Results (Standalone and Consolidated) of the Company
for the Quarter ended 30th June, 2026.
Please take the above information on your records.
Thanking you,
Yours sincerely,
For Astec LifeSciences Limited
Tejashree Pradhan
Company Secretary & Compliance Officer
(FCS 7167)
Encl.: As above
Astec LifeSciences Limited
Corporate Identity Number : L99999MH1994PLC076236
Registered Office : Godrej One, 3rd Floor, Pirojshanagar, Eastern Express Highway, Vikhroli (East), Mumbai-400079, Maharashtra
Website: www.godrejastec.com, Tel no.: 022-2519 5768, Fax no.: 022-2261 8289, Email id: astecinvestors@godrejastec.com
STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026
(Rs. in lakhs)
Standalone Consolidated
Quarter Ended Year Ended Quarter Ended Year Ended
30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26
(Unaudited) (Refer Note 4) (Unaudited) (Audited) (Unaudited) (Refer Note 4) (Unaudited) (Audited)
INCOME
8,356.43 15,862.27 9,108.21 44,814.56 Revenue From Operations 8,356.43 15,862.26 9,108.21 44,814.56
70.85 261.41 48.66 498.87 Other Income 72.74 263.36 50.65 507.09
8,427.28 16,123.68 9,156.87 45,313.43 TOTAL INCOME 8,429.17 16,125.62 9,158.86 45,321.65
EXPENSES
7,632.28 7,127.45 5,940.62 27,045.00 Cost of materials consumed 7,632.28 7,127.45 5,940.62 27,045.01
Changes in inventories of finished goods and Work-in-
(3,370.38) 3,906.16 447.77 2,796.44 (3,370.38) 3,906.17 447.77 2,796.44
progress
1,599.96 1,632.12 1,518.41 6,290.81 Employee benefits expense 1,599.96 1,632.12 1,518.41 6,290.81
773.99 793.33 1,104.90 3,456.76 Finance costs 773.18 792.22 1,104.38 3,452.89
1,108.62 1,178.82 1,151.02 4,499.34 Depreciation and amortisation expenses 1,106.77 1,176.97 1,149.41 4,492.18
2,560.73 2,280.29 2,299.79 9,132.84 Other expenses 2,561.18 2,280.70 2,300.02 9,134.90
10,305.20 16,918.17 12,462.51 53,221.19 TOTAL EXPENSES 10,302.99 16,915.63 12,460.61 53,212.23
(1,877.92) (794.49) (3,305.64) (7,907.76) LOSS BEFORE EXCEPTIONAL ITEMS & TAX (1,873.82) (790.01) (3,301.75) (7,890.58)
- - - 209.43 Exceptional items (Refer Note 3) - - - 209.43
(1,877.92) (794.49) (3,305.64) (8,117.19) LOSS BEFORE TAX (1,873.82) (790.01) (3,301.75) (8,100.01)
(4.08) (16.31) - (16.31) Tax expense: (3.o9) (15.31) 0.94 (12.39)
- - - - 1. Current tax 0.98 0.99 1.06 4.00
(4.08) (16.31) - (16.31) 2. Deferred tax expense/ (income) (4.07) (16.30) (0.12) (16.39)
(1,873.84) (778.18) {3,305.64) (8,100.88) LOSS AFTER TAX FOR THE PERIOD/YEAR (1,870.73) (774.70) (3,302.69) (8,087.62)
.. Auf0.\>8\ r
!'fl '"f, •
~ ,O.t
t,; .... ~
(Rs. in lakhs)
Standalone Consolidated
Quarter Ended Year Ended Quarter Ended Year Ended
30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26
(Unaudited) (Refer Note 4) (Unaudited) (Audited) (Unaudited) (Refer Note 4) (Unaudited) (Audited)
OTHER COMPREHENSIVE INCOME
16.20 38.04 5.64 64.80 (A) (i) Items that will not be reclassified to profit or loss 16.20 38.04 5.64 64.80
(ii) Income tax related to Items that will not be
(4.08) (16.31) - (16.31) reclassified to profit or loss (4.08) (16.31) - (16.31)
- - - - (B) (i) Items that will be reclassified to profit or loss (0.77) (0.70) (0.29) (2.32)
(ii) Income tax related to items that will be
- - - - reclassified to profit or loss - - - -
TOTAL OTHER COMPREHENSIVE INCOME
12.12 21.73 5.64 48.49 FOR THE YEAR, NET OF INCOME TAX 11.35 21.03 5.35 46.17
TOTAL COMPREHENSIVE LOSS FOR THE
(1,861.72) (756.45) (3,300.00) (8,052.39) YEAR (1,859.38) (753.67) (3,297.34) (8,041.45)
Loss for the period attributable to:
a) Owners of the Company (1,871.74) (775.73) (3,303.78) (8,091.75)
b) Non Controlling Interest 1.01 1.03 1.09 4.13
Other Comprehensive Income attributable to:
a) Owners of the Company 11.35 21.03 5.35 46.17
b) Non Controlling Interest - - - -
Total Comprehensive Loss attributable to:
a) Owners of the Company (1,860.39) (754.70) (3,298.43) (8,045.58)
b) Non Controlling Interest 1.01 1.03 1.09 4.13
Paid-up Equity share capital (Face Value Rs. 10 per
2,228.28 2,228.22 1,961.17 2,228.22 share) 2,228.28 2,228.22 1,961.17 2,228.22
36,758.42 Other Equity 36,832.36
Earnings per equity share of Rs. 10 each
(non-annualized)
(8.41) (3.49) (16.86) (37.83) Basic (Rs.) (8.40) (3.48) (16.85) (37.79)
(8.41) (3.49) (16.85) (37.83) Diluted (Rs.) (8.40) (3.48) (16.85) (37.79)
Aste< LifeSciences Limited
Corporate Identity Number : L99999MH1994PLC076236
Registered Office: Godrej One, 3rd Floor, Pirojshanagar, Eastern Express Highway, Vikbroli (East), Mumbai-400079, Maharashtra
Website: www.godrejastec.com, Tel no.: 022-2519 5768, Fax no.: 022-2261 8289, Email Id: astecinvestors@godrejastec.com
Additional disclosures as per Clause 52( 4) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Standalone Consolidated
Quarter Ended Year ended Quarter Ended Year ended
30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26
(Unaudited) (Refer Note 4) (Unaudited I (Audited) (Unaudited) (Refer Note 4) (Unaudited) (Audited)
0.83 0.88 0.78 0.88 Current Ratio (refer note 1) 0.83 0.89 0.78 0.89
37,128.05 38,986.64 20,112.25 38,986.64 Net Worth (in Rs. Lakh) 37,235.59 39,091.84 20,iS0.95 39,091.79
Outstanding redeemable preference shares (quantity and
- value) - -
(1,873.84) (778.18) (3,305.64) (8,100.88) Net profit/(loss) after tax (in Rs. Lakh) (i,870.73) (774.70) (3,302.69) (8,087.62)
(8.41) (3.49) (16.86) (37.83) Basic Earnings per share (8.40) (3.48) (16.85) (37.79)
(8.41) (3.49) (16.85) (37.83) Diluted Earnings per share (8.40) (3.48) (16.85) (37.79)
0.30 0.30 0.30 0.30 Capital Redemption Reserve (in Rs. Lakh) 0.30 0.30 0.30 0.30
0.99 1.15 2.96 1.15 Debt Equity ratio (refer note I) 0.98 1.15 2.95 1.15
0.01 0.66 (0.21) (0.01) Debt Service Coverage Ratio (DSCR) (refer note 1) 0.01 0.66 (0.21.) (0.01)
0.03 I.SO (0.95) (0.04) Interest Service Coverage Ratio (ISCR) (refer note I) O.o3 1.51 (0.95) (0.04)
8.65 4.49 4.49 Long term debt to working capital (refer note I) 7.93 4.31 4.31
- - - - Bad debts to Account receivable ratio (refer note 1) - - -
0.73 0.74 0.62 0.74 Current liability ratio (refernote I) 0.73 0.75 0.62 0.75
0.43 0.48 0.68 0.48 Total debts to total assets (refer note I) 0.43 0.48 0.68 0.48
1.61 2.87 2.77 2.25 Debtors turnover (refer note I) 1.61 2.87 2.77 2.25
2.15 4.02 2.33 3.01 Inventory turnover (r
[Showing first 8,000 characters — download PDF for full document]